Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Metastatic Endometrial Cancer”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Testing effectiveness (Phase 2)Study completedNCT00003127
What this trial is testing

S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer

Who this might be right for
Endometrial Cancer
SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)Study completedNCT01935934
What this trial is testing

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more
National Cancer Institute (NCI) 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT05538897
What this trial is testing

Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

Who this might be right for
FIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaMetastatic Endometrial Endometrioid Adenocarcinoma+1 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Looking for participantsNCT03651206
What this trial is testing

Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib

Who this might be right for
Ovarian CarcinosarcomaEndometrial Carcinosarcoma
ARCAGY/ GINECO GROUP 138
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06751277
What this trial is testing

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Recurrent or Metastatic Endometrial Cancer
xiang yang 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT02912572
What this trial is testing

Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer

Who this might be right for
Metastatic Endometrial Cancer
Dana-Farber Cancer Institute 106
Testing effectiveness (Phase 2)Ended earlyNCT03485729
What this trial is testing

ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer

Who this might be right for
Endometrial Cancer Recurrent
Jazz Pharmaceuticals 27
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Ended earlyNCT00016341
What this trial is testing

Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Not applicableStudy completedNCT05364905
What this trial is testing

Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma

Who this might be right for
OncologyEndometrial CancerAdvanced Cancer+2 more
ARCAGY/ GINECO GROUP 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06620029
What this trial is testing

BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer

Who this might be right for
Ovarian NeoplasmsEndometrial Cancer, Endometrial Neoplasm
BioMimetix JV, LLC 27
Testing effectiveness (Phase 2)Looking for participantsNCT05564377
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Who this might be right for
Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+12 more
National Cancer Institute (NCI) 2,900
Testing effectiveness (Phase 2)Ended earlyNCT01251354
What this trial is testing

Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

Who this might be right for
Endometrial Cancer
Ipsen 6
Testing effectiveness (Phase 2)Study completedNCT00249990
What this trial is testing

Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)

Who this might be right for
Corpus UteriEndometrial Cancer
University of New Mexico 39
Testing effectiveness (Phase 2)Looking for participantsNCT07054567
What this trial is testing

BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer

Who this might be right for
Cervical CancerEndometrial Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 96
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Active Not RecruitingNCT05691504
What this trial is testing

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00478426
What this trial is testing

Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Serous Adenocarcinoma+5 more
National Cancer Institute (NCI) 34
Large-scale testing (Phase 3)UnknownNCT02584478
What this trial is testing

Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)

Who this might be right for
Endometrial CarcinomaOvarian CarcinomaFallopian Tube Carcinoma+2 more
Advenchen Laboratories, LLC 294
Testing effectiveness (Phase 2)Study completedNCT04205630
What this trial is testing

SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
Byondis B.V. 64
Next Page
96